-
1
-
-
79955826864
-
2010 Update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
-
Braun J, van den Berg R, Baraliakos X, et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2011;70:896-904.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 896-904
-
-
Braun, J.1
Van Den Berg, R.2
Baraliakos, X.3
-
2
-
-
0017265072
-
Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone
-
Boersma JW. Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone. Scan J Rheumatol 1976;5:60-4.
-
(1976)
Scan J Rheumatol
, vol.5
, pp. 60-64
-
-
Boersma, J.W.1
-
3
-
-
20744445686
-
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial
-
DOI 10.1002/art.21054
-
Wanders A, Heijde D, Landewe R, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 2005;52:1756-65. (Pubitemid 40852884)
-
(2005)
Arthritis and Rheumatism
, vol.52
, Issue.6
, pp. 1756-1765
-
-
Wanders, A.1
Van Der, H.D.2
Landewe, R.3
Behier, J.-M.4
Calin, A.5
Olivieri, I.6
Zeidler, H.7
Dougados, M.8
-
4
-
-
84863910861
-
Continuance of non-steroidal anti-inflammatory drugs may reduce radiographic progression in ankylosing spondylitis patients on biological therapy
-
Haroon N, Shen H, Carty A, et al. Continuance of non-steroidal anti-inflammatory drugs may reduce radiographic progression in ankylosing spondylitis patients on biological therapy. Arthritis Rheum 2011;63:1303.
-
(2011)
Arthritis Rheum
, vol.63
, pp. 1303
-
-
Haroon, N.1
Shen, H.2
Carty, A.3
-
5
-
-
84866106871
-
Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: Results from the German Spondyloarthritis Inception Cohort
-
Poddubnyy D, Rudwaleit M, Haibel H, et al. Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis 2012.
-
(2012)
Ann Rheum Dis
-
-
Poddubnyy, D.1
Rudwaleit, M.2
Haibel, H.3
-
6
-
-
85027933537
-
Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis
-
Kroon F, Landewe R, Dougados M, et al. Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis 2012.
-
(2012)
Ann Rheum Dis
-
-
Kroon, F.1
Landewe, R.2
Dougados, M.3
-
7
-
-
0030028099
-
Aspirin and NSAID use in older women: Effect on bone mineral density and fracture risk
-
Bauer DC, Orwoll ES, Fox KM, et al. Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1996;11:29-35. (Pubitemid 26026741)
-
(1996)
Journal of Bone and Mineral Research
, vol.11
, Issue.1
, pp. 29-35
-
-
Bauer, D.C.1
Orwoll, E.S.2
Fox, K.M.3
Vogt, T.M.4
Lane, N.E.5
Hochberg, M.C.6
Stone, K.7
Nevitt, M.C.8
-
8
-
-
0031789431
-
Nonsteroidal anti-inflammatory drugs and bone mineral density in older women: The Rancho Bernardo study
-
Morton DJ, Barrett-Connor EL, Schneider DL. Nonsteroidal anti-inflammatory drugs and bone mineral density in older women: the Rancho Bernardo study. J Bone Miner Res 1998;13:1924-31. (Pubitemid 28535850)
-
(1998)
Journal of Bone and Mineral Research
, vol.13
, Issue.12
, pp. 1924-1931
-
-
Morton, D.J.1
Barrett-Connor, E.L.2
Schneider, D.L.3
-
9
-
-
84861740129
-
Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: Results of the Danish Osteoporosis Prevention Study (DOPS)
-
Vestergaard P, Hermann P, Jensen JE, et al. Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS). Osteoporos Int 2012;23:1255-65.
-
(2012)
Osteoporos Int
, vol.23
, pp. 1255-1265
-
-
Vestergaard, P.1
Hermann, P.2
Jensen, J.E.3
-
10
-
-
33746387887
-
The effect of cyclooxygenase-2 inhibitors on bone mineral density: Results from the Canadian Multicentre Osteoporosis Study
-
DOI 10.1007/s00198-006-0142-x
-
Richards JB, Joseph L, Schwartzman K, et al. The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from the Canadian Multicentre Osteoporosis Study. Osteoporos Int 2006;17:1410-19. (Pubitemid 44127329)
-
(2006)
Osteoporosis International
, vol.17
, Issue.9
, pp. 1410-1419
-
-
Richards, J.B.1
Joseph, L.2
Schwartzman, K.3
Kreiger, N.4
Tenenhouse, A.5
Goltzman, D.6
-
11
-
-
79953819693
-
High-dose ketorolac affects adult spinal fusion: A meta-analysis of the effect of perioperative nonsteroidal anti-inflammatory drugs on spinal fusion
-
Li Q, Zhang Z, Cai Z. High-dose ketorolac affects adult spinal fusion: a meta-analysis of the effect of perioperative nonsteroidal anti-inflammatory drugs on spinal fusion. Spine 2011;36:461-8.
-
(2011)
Spine
, vol.36
, pp. 461-468
-
-
Li, Q.1
Zhang, Z.2
Cai, Z.3
-
12
-
-
21244499365
-
High dose nonsteroidal anti-inflammatory drugs compromise spinal fusion
-
Reuben SS, Ablett D, Kaye R. High dose nonsteroidal anti-inflammatory drugs compromise spinal fusion. Can J Anaesth 2005; 52:506-12. (Pubitemid 40883312)
-
(2005)
Canadian Journal of Anesthesia
, vol.52
, Issue.5
, pp. 506-512
-
-
Reuben, S.S.1
Ablett, D.2
Kaye, R.3
-
13
-
-
0032055707
-
The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion
-
DOI 10.1097/00007632-199804010-00020
-
Glassman SD, Rose SM, Dimar JR, et al. The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion. Spine 1998;23:834-8. (Pubitemid 28169215)
-
(1998)
Spine
, vol.23
, Issue.7
, pp. 834-838
-
-
Glassman, S.D.1
Rose, S.M.2
Dimar, J.R.3
Puno, R.M.4
Campbell, M.J.5
Johnson, J.R.6
-
14
-
-
0345151815
-
Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion
-
DOI 10.1097/00007632-199911010-00003
-
Martin GJ Jr, Boden SD, Titus L. Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion. Spine 1999;24:2188-94. (Pubitemid 29518020)
-
(1999)
Spine
, vol.24
, Issue.21
, pp. 2188-2194
-
-
Martin Jr., G.J.1
Boden, S.D.2
Titus, L.3
-
15
-
-
77951456440
-
BMP-7-induced ectopic bone formation and fracture healing is impaired by systemic NSAID application in C57BL/6-mice
-
Spiro AS, Beil FT, Baranowsky A, et al. BMP-7-induced ectopic bone formation and fracture healing is impaired by systemic NSAID application in C57BL/6-mice. J Orthop Res 2010;28:785-91.
-
(2010)
J Orthop Res
, vol.28
, pp. 785-791
-
-
Spiro, A.S.1
Beil, F.T.2
Baranowsky, A.3
-
16
-
-
79960899377
-
Australo-Anglo-American Spondyloarthritis Consortium (TASC), the Wellcome Trust Case Control Consortium 2 (WTCCC2). Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility
-
Evans DM, Spencer CC, Pointon JJ, et al., Australo-Anglo-American Spondyloarthritis Consortium (TASC), the Wellcome Trust Case Control Consortium 2 (WTCCC2). Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011;43:761-7.
-
(2011)
Nat Genet
, vol.43
, pp. 761-767
-
-
Evans, D.M.1
Spencer, C.C.2
Pointon, J.J.3
-
17
-
-
0034733567
-
2 in prostaglandin E receptor EP4-knockout mice
-
DOI 10.1074/jbc.M002079200
-
Miyaura C, Inada M, Suzawa T, et al. Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice. J Biol Chem 2000;275:19819-23. (Pubitemid 30441583)
-
(2000)
Journal of Biological Chemistry
, vol.275
, Issue.26
, pp. 19819-19823
-
-
Miyaura, C.1
Inada, M.2
Suzawa, T.3
Sugimoto, Y.4
Ushikubi, F.5
Ichikawa, A.6
Narumiya, S.7
Suda, T.8
-
18
-
-
0034440540
-
Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype
-
DOI 10.1128/IAI.68.12.6819-6825.2000
-
Sakuma Y, Tanaka K, Suda M, et al. Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype. Infect Immun 2000;68:6819-25. (Pubitemid 32463389)
-
(2000)
Infection and Immunity
, vol.68
, Issue.12
, pp. 6819-6825
-
-
Sakuma, Y.1
Tanaka, K.2
Suda, M.3
Komatsu, Y.4
Yasoda, A.5
Miura, M.6
Ozasa, A.7
Narumiya, S.8
Sugimoto, Y.9
Ichikawa, A.10
Ushikubi, F.11
Nakao, K.12
-
19
-
-
79961100171
-
Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis
-
Chiowchanwisawakit P, Lambert RG, Conner-Spady B, et al. Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum 2011;63:2215-25.
-
(2011)
Arthritis Rheum
, vol.63
, pp. 2215-2225
-
-
Chiowchanwisawakit, P.1
Lambert, R.G.2
Conner-Spady, B.3
-
20
-
-
34548246050
-
Effects of basic fibroblast growth factor and a prostaglandin E2 receptor subtype 4 agonist on osteoblastogenesis and adipogenesis in aged ovariectomized rats
-
DOI 10.1359/jbmr.070313
-
Aguirre JI, Leal ME, Rivera MF, et al. Effects of basic fibroblast growth factor and a prostaglandin E2 receptor subtype 4 agonist on osteoblastogenesis and adipogenesis in aged ovariectomized rats. J Bone Miner Res 2007;22:877-88. (Pubitemid 351339748)
-
(2007)
Journal of Bone and Mineral Research
, vol.22
, Issue.6
, pp. 877-888
-
-
Aguirre, J.I.1
Leal, M.E.2
Rivera, M.F.3
Vanegas, S.M.4
Jorgensen, M.5
Wronski, T.J.6
-
22
-
-
84865223667
-
Prostaglandin E(2) affects osteoblast biology in a dose-dependent manner: An in vitro study
-
Ramirez-Yanez GO, Symons AL. Prostaglandin E(2) affects osteoblast biology in a dose-dependent manner: an in vitro study. Arch Oral Biol 2012;57:1274-81.
-
(2012)
Arch Oral Biol
, vol.57
, pp. 1274-1281
-
-
Ramirez-Yanez, G.O.1
Symons, A.L.2
-
23
-
-
77955005184
-
Clinical significance of inflammatory back pain for diagnosis and screening of patients with axial spondyloarthritis
-
Braun J, Inman R. Clinical significance of inflammatory back pain for diagnosis and screening of patients with axial spondyloarthritis. Ann Rheum Dis 2010;69:1264-8.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1264-1268
-
-
Braun, J.1
Inman, R.2
-
24
-
-
84860436138
-
Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis
-
Poddubnyy D, Haibel H, Listing J, et al. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 2012;64:1388-98.
-
(2012)
Arthritis Rheum
, vol.64
, pp. 1388-1398
-
-
Poddubnyy, D.1
Haibel, H.2
Listing, J.3
-
25
-
-
69949166113
-
Comparison of clinical and radiographic severity of juvenile-onset versus adult-onset ankylosing spondylitis
-
O'Shea FD, Boyle E, Riarh R, et al. Comparison of clinical and radiographic severity of juvenile-onset versus adult-onset ankylosing spondylitis. Ann Rheum Dis 2009;68:1407-12.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1407-1412
-
-
O'Shea, F.D.1
Boyle, E.2
Riarh, R.3
-
26
-
-
34249816449
-
Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis
-
DOI 10.1002/art.22589
-
Maksymowych WP, Landewe R, Conner-Spady B, et al. Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum 2007;56:1846-53. (Pubitemid 47110384)
-
(2007)
Arthritis and Rheumatism
, vol.56
, Issue.6
, pp. 1846-1853
-
-
Maksymowych, W.P.1
Landewe, R.2
Conner-Spady, B.3
Dougados, M.4
Mielants, H.5
Van Der, T.H.6
Poole, A.R.7
Wang, N.8
Van Der, H.D.9
-
27
-
-
84857910076
-
High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis
-
Heiland GR, Appel H, Poddubnyy D, et al. High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann Rheum Dis 2012;71:572-4.
-
(2012)
Ann Rheum Dis
, vol.71
, pp. 572-574
-
-
Heiland, G.R.1
Appel, H.2
Poddubnyy, D.3
-
28
-
-
84872220723
-
Elevated levels of Wnt3a and low levels of Dickkopf-1 in serum are associated with syndesmophyte formation in ankylosing spondylitis
-
Klingberg E, Merja Nurkkala M, Hans Carlsten H, et al. Elevated levels of Wnt3a and low levels of Dickkopf-1 in serum are associated with syndesmophyte formation in ankylosing spondylitis. Ann Rheum Dis 2012;71:A64.
-
(2012)
Ann Rheum Dis
, vol.71
-
-
Klingberg, E.1
Merja Nurkkala, M.2
Hans Carlsten, H.3
-
29
-
-
70350558488
-
Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis
-
Appel H, Ruiz-Heiland G, Listing J, et al. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum 2009;60:3257-62.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 3257-3262
-
-
Appel, H.1
Ruiz-Heiland, G.2
Listing, J.3
-
30
-
-
84866178568
-
Radiographic severity in ankylosing spondylitis is associated with polymorphism in large multifunctional peptidase 2 (LMP2) in the SPARCC cohort
-
Haroon N, Maksymowych W, Rahman P, et al. Radiographic severity in ankylosing spondylitis is associated with polymorphism in large multifunctional peptidase 2 (LMP2) in the SPARCC cohort. Arthritis Rheum 2012;64:1119-26.
-
(2012)
Arthritis Rheum
, vol.64
, pp. 1119-1126
-
-
Haroon, N.1
Maksymowych, W.2
Rahman, P.3
-
31
-
-
84857920282
-
Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: A longitudinal study
-
van Tubergen A, Ramiro S, van der Heijde D, et al. Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study. Ann Rheum Dis 2012;71:518-23.
-
(2012)
Ann Rheum Dis
, vol.71
, pp. 518-523
-
-
Van Tubergen, A.1
Ramiro, S.2
Van Der Heijde, D.3
-
32
-
-
65249152431
-
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis
-
Ciccia F, Bombardieri M, Principato A, et al. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum 2009;60:955-65.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 955-965
-
-
Ciccia, F.1
Bombardieri, M.2
Principato, A.3
-
33
-
-
73649145825
-
Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis
-
Peters MJ, van Eijk IC, Smulders YM, et al. Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis. J Rheumatol 2010;37:161-6.
-
(2010)
J Rheumatol
, vol.37
, pp. 161-166
-
-
Peters, M.J.1
Van Eijk, I.C.2
Smulders, Y.M.3
-
34
-
-
80053569408
-
Increased mortality in ankylosing spondylitis is related to disease activity
-
Bakland G, Gran JT, Nossent JC. Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 2011;70:1921-5.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 1921-1925
-
-
Bakland, G.1
Gran, J.T.2
Nossent, J.C.3
-
35
-
-
61449165874
-
Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: Results from a primary care based inception cohort of patients
-
Goodson NJ, Brookhart AM, Symmons DP, et al. Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients. Ann Rheum Dis 2009;68:367-72.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 367-372
-
-
Goodson, N.J.1
Brookhart, A.M.2
Symmons, D.P.3
-
36
-
-
82955236087
-
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
-
Gossec L, Smolen JS, Gaujoux-Viala C, et al. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis 2012;71:4-12.
-
(2012)
Ann Rheum Dis
, vol.71
, pp. 4-12
-
-
Gossec, L.1
Smolen, J.S.2
Gaujoux-Viala, C.3
|